Clinical significance of inactivated glycogen synthase kinase 3β in HPV-associated cervical cancer: Relationship with Wnt/β-Catenin pathway activation

American Journal of Reproductive Immunology

Volumn 73, Issue 5, 2015, Pages 460-478

  Rath, Gayatri ^a   Jawanjal, Poonam ^a   Salhan, Sudha ^a   Nalliah, Manoharan ^b   Dhawan, Indrani ^a  

^a SAFDARJUNG HOSPITAL   (India)

^b INSTITUTE ROTARY CANCER HOSPITAL   (India)

Author keywords

C Myc; Cervical intra epithelial neoplasia; HPV 16 18; pGSK3 Try216 pGSK3 Ser9; Squamous cell carcinoma; Wnt catenin pathway

Indexed keywords

BETA CATENIN; GLYCOGEN SYNTHASE KINASE 3BETA; MYC PROTEIN; WNT PROTEIN; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; MYC PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CANCER SIZE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA EXTRACTION; ENZYME INACTIVATION; ENZYME PHOSPHORYLATION; FEMALE; GENOTYPE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MIXED INFECTION; MULTIPLEX POLYMERASE CHAIN REACTION; ONCOGENE C MYC; ORAL CONTRACEPTION; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; WESTERN BLOTTING; BIOSYNTHESIS; CLINICAL TRIAL; GENE EXPRESSION REGULATION; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; PATHOLOGY; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX TUMOR; VERY ELDERLY; VIROLOGY; WNT SIGNALING PATHWAY;

ADULT; AGED; AGED, 80 AND OVER; BETA CATENIN; CARCINOMA, SQUAMOUS CELL; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOGEN SYNTHASE KINASE 3; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMANS; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PROTO-ONCOGENE PROTEINS C-MYC; UTERINE CERVICAL NEOPLASMS; WNT SIGNALING PATHWAY;

EID: 84927114060     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/aji.12346     Document Type: Article

References (72)

1. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F: GLOBOCAN 2012, v 1.0, Cancer Incidence and Mortality Worldwide. IARC Cancer Base;11. Lyon, France, International Agency for Research on Cancer, 2013. http://globocan.iarc.fr.
2. Zur Hausen H: Papilloma viruses causing cancer: evasion from host cell control in early events in carcinogenesis. J Natl Cancer Inst 2000; 92:690-698.
3. Bhatla N, Dar L, Rajkumar PA, Kumar P, Pati SK, Kriplani A, Gulati A, Broor S, Ayer VK, Mathur S, Shah KV, Gravitt PE: Human papilloma viruses-type distribution in women with and without cervical neoplasia in north India. Int J Gynecol Path 2008; 27:426-430.
4. Sobti RC, Singh N, Hussain S, Suri V, Bharti AC, Das BC: Over-expression of STAT3 in HPV-mediated cervical cancer in a North Indian population. Mol Cell Biochem 2009; 330:193-199.
5. Plasencia PC, Ortiz V, Lopaz RR, Pina SP, Moreno J, Salcedo M: Genome wide expression analysis in HPV 16 cervical cancer: identification of altered metabolic pathways. Infect Agent Cancer 2007; 2:16.
6. Rampias T, Boutati E, Pectasides E, Sasaki C, Kountourakis P, Weillnberg P, Psyrri A: Activation of Wnt signaling pathway by human papillomavirus E6 and E7 oncogenes in HPV16-positive oropharyngeal squamous carcinoma cells. Mol Cancer Res 2010; 8:433-443.
7. Bulut G, Fallen S, Beauchamp EM, Drebing LE, Sun J, Berry DL, Kallakury B, Crum CP, Toretsky JA, Schlegel R, Uren A: β-catenin accelerates human papilloma virus type-16 mediated cervical carcinogenesis in transgenic mice. PLoS One 2011; 6:e27243.
8. Delgado JB, Bulut G, Liu X, Cortes-Malagon CM, Schlegel R, Maldonado CF, Contrera RG, Gariglio P: The E6 oncoprotein from HPV16 enhances the canonical Wnt/β-catenin pathway in skin epidermis in vivo. Mol Cancer Res 2012; 10:250-258.
9. Kim M, Datta A, Brakeman P, Yu W, Mostov KE: Polarity proteins PAR6 and PKC regulate cell death through GSK-3beta in 3D epithelial morphogenesis. J Cell Sci 2007; 120:2309-2317.
10. Doble BW, Woodgett JR: GSK-3: tricks of the trade for multitasking kinase. J Cell Sci 2003; 116:1175-1186.
11. Jope RS, Johnson GV: The glamour and gloom of glycogen synthase kinase-3. Trends Biochem Sci 2004; 29:95-102.
12. Mishra R: Glycogen synthase kinase 3 beta: can it be a target for oral cancer. Mol Cancer 2010; 9:144.
13. Logan CY, Nusse R: The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol 2004; 20:781-810.
14. Liu C, Li Y, Semenov M, Han C, Baeg GH, Tan Y, Zhang Z, Lin X, He X: Control of b-catenin phosphorylation/degradation by dual kinase mechanism. Cell 2002; 108:837-847.
15. Behrens J, Jerchow BA, Wurtele M, Grimm J, Asbrand C, Wirtz R, Kuhl M, Wedlich D, Birchmeier W: Functional interaction of an axin homolog, conductin, with beta-catenin, APC, and GSK3beta. Science 1998; 280:596-599.
16. Hart MJ, de los Santos R, Albert IN, Rubinfeld B, Polakis P: Downregulation of beta-catenin by human Axin and its association with APC tumor suppressor, beta-catenin and GSK3beta. Curr Biol 1998; 8:573-581.
17. Ikeda S, Kishida S, Yamamoto H, Murai H, Koyama S, Kikuchi A: Axin, a negative regulator of Wnt signaling pathway, forms a complex with GSK3β and β-catenin and promotes GSK-3β-dependent phosphorylation of β-catenin. EMBO J 1998; 17:1371-1384.
18. Sutherland C, Leighton IA, Cohen P: Inactivation of glycogen synthase kinase-3β by phosphorylation: new kinase connections in insulin and growth-factor signalling. Biochem J 1993; 296:15-19.
19. Stambolic V, Woodgett JR: Mitogen inactivation of glycogen synthase kinase-3β in intact cells via serine 9 phosphorylation. Biochem J 1994; 303:701-704.
20. Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemming BA: Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 1995; 378:785-789.
21. Li L, Yuan H, Weaver CD, Mao J, Farr III GH, Sussman DJ, Jonkers J, Kimelman D, Wu D: Axin and Frat1 interact with Dvl and GSK, bridging Dvl to GSK in Wnt-mediated regulation of LEF-1. EMBO J 1999; 18:4233-4240.
22. Salic A, Lee E, Mayer L, Kirschner MW: Control of beta-catenin stability: reconstitution of the cytoplasmic steps of the wnt pathway in Xenopus egg extracts. Mol Cell 2000; 5:523-532.
23. Farr GH III, Ferkey DM, Yost C, Pierce SB, Weaver C, Kimelman D: Interaction among GSK-3, GBP, Axin, and APC in Xenopus axis specification. J Cell Biol 2001; 148:691-702.
24. Goto H, Kawano K, Kobayashi I, Sakai H, Yanagisawa S: Expression of cyclin D1 and GSK3-beta and their predictive value of prognosis in squamous cell carcinoma of tongue. Oral Oncol 2002; 38:549-556.
25. 9 and EGFR are good prognostic factors for lung carcinomas. Antican Res 2007; 27:3561-3570.
26. Prasad CP, Rath G, Mathur S, Bhatnagar D, Parshad R, Ralhan R: Expression analysis of E-cadherin, slug and GSK3β in invasive ductal carcinoma of breast. BMC Can 2009; 9:325.
27. Zhang Y, Shu YM, Wang SW, Da BH, Wang ZH, Li HB: Stabilization of mismatch repair gene PMS2 by glycogen synthase kinase 3β is implicated in treatment of cervical carcinoma. BMC Can 2010; 10:58.
28. Jawanjal P, Salhan S, Dhavan I, Tripathi R, Rath G: Peptidyl-prolyl isomerase Pin1-mediated abrogation of APC-β-catenin interaction in squamous cell carcinoma of cervix. Rom J Morphol Embryol 2014; 55:3-6.
29. Gregory MA, Qi Y, Hann SR: Phosphorylation by glycogen synthase kinase-3 controls c-Myc proteolysis and subnuclear localization. J Biol Chem 2003; 278:51606-51612.
30. Yada M, Hatakeyama S, Kamura T, Nishiyama M, Tsunematsu R, Imaki H, Ishida N, Okumura F, Nakayama K, Nakayama KI: Phosphorylation-dependent degradation of c-Myc is mediated by F-box protein Fbw7. EMBO J 2004; 23:2116-2125.
31. Bahram F, von der Lehr N, Cetinkaya C, Larsson LG: c-Myc hot spot mutations in lymphomas result in inefficient ubiquitination and decreased proteasome-mediated turnover. Blood 2000;95:2104-2110.
32. An J, Yang DY, Xu QZ, Zhang SM, Huo YY, Shang ZF, Wang Y, Wu DC, Zhou PK: DNA-dependent protein kinase catalytic subunit modulates the stability of c-Myc oncoprotein. Mol Cancer 2008; 7:32.
33. Kong TW, Chang SJ, Paek J, Yoo SC, Yoon JH, Chang KH, Chun M, Ryu HS: Comparison of concurrent chemoradiation therapy with weekly cisplatin verses monthly fluorouracil plus cisplatin in FIGO stage IIB-IVA cervical cancer. J Gynecol Oncol 2012; 23:235-241.
34. Shepherd JH: Cervical and vulva cancer: changes in FIGO definitions of staging. Br J Obstet Gynaecol 1996; 103:405-406.
35. Sobti RC, Singh N, Hussain S, Suri V, Bharti AC, Das BC: Over-expression of STAT3 in HPV-mediated cervical cancer in a North Indian population. Mol Cell Biochem 2009; 330:193-199.
36. Das BC, Hussain S, Nasare V, Bharadwaj M: Prospects and prejudices of human papillomavirus vaccines in India. Vaccine 2008; 26:2669-2679.
37. Lillo FB, Foppa CU: Human papilloma virus viral load: a possible marker for cervical disease in HIV-infected women. J Antimicro Chem 2006; 57:810-814.
38. Colafrancesco S, Perricone C, Tomljenovic L, Shoenfeld Y: Human papilloma virus vaccine and primary ovarian failure: another facet of the autoimmune/inflammatory syndrome induced by adjuvants. Am J Reprod Immunol 2013; 70:309-316.
39. Molina AA, Hernández-Valencia JF, Lamoyi E, Contreras-Paredes A, Lizano M: Role of innate immunity against human papillomavirus (HPV) infections and effect of adjuvants in promoting specific immune response. Viruses 2013; 5:2624-2642.
40. Jacobs N, Renard I, Al-Saleh W, Hubert P, Doyen J, Kedzia W, Boniver J, Delvenne P: Distinct T cell subsets and cytokine production in cultures derived from transformation zone and squamous intraepithelial lesion biopsies of the uterine cervix. Am J Reprod Immunol 2003; 49:6-13.
41. Kanodia S, Fahey LM, Kast WM: Mechanisms used by human papillomaviruses to escape the host immune response. Curr Cancer Drug Targets 2007; 7:79-89.
42. Adurthi S, Krishna S, Mukherjee G, Bafna UD, Devi U, Jayshree RS: Regulatory T cells in a spectrum of HPV-induced cervical lesions: cervicitis, cervical intraepithelial neoplasia and squamous cell carcinoma. Am J Reprod Immunol 2008; 60:55-65.
43. Bolpetti A, Silva JS, Villa LL, Lepique AP: Interleukin-10 production by tumor infiltrating macrophages plays a role in human papillomavirus 16 tumor growth. BMC Immunol 2010; 11:27.
44. Bermudez-Morales VH, Peralta-Zaragoza O, Alcocer-Gonzalez JM, Moreno J, Madrid-Marina V: IL-10 expression is regulated by HPV E2 protein in cervical cancer cells. Mol Med Rep 2011; 4:369-375.
45. Luo J: Glycogen synthase kinase 3β (GSK3β) in tumorigenesis and cancer chemotherapy. Cancer Lett 2009; 273:194-200.
46. Grimes CA, Jope RS: The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling. Prog Neurobiol 2001; 65:391-426.
47. Beurel E, Kornprobst M, Blivet-Van Eggelpoel MJ, Cadoret A, Capeau J, Desbois-Mouthon C: GSK-3beta reactivation with LY294002 sensitizes hepatoma cells to chemotherapy-induced apoptosis. Int J Oncol 2005; 27:215-222.
48. Leis H, Segrelles C, Ruiz S, Santos M, Paramio JM: Expression, localization and activity of glycogen synthase kinase 3beta during mouse skin tumorigenesis. Mol Carcinog 2002; 35:180-185.
49. Kang T, Wei Y, Chiang YC, Yamaguch H, Appella E, Hung MC, Worms HP: GSK-3beta targets Cdc25A for ubiquitin-mediated proteolysis and GSK-3beta inactivation correlates with Cdc25A overproduction in human cancers. Cancer Cell 2008; 13:36-47.
50. Ma C, Wang J, Gao Y, Gao TW, Chen G, Bower KA, Odetallah M, Ding M, Ke Z, Luo J: The role of glycogen synthase kinase 3beta in the transformation of epidermal cells. Cancer Res 2007; 67:7756-7764.
51. Tian D, Zhu M, Chen WS, Li JS, Wu RL, Wang X: Role of glycogen synthase kinase 3beta in squamous differentiation induced by cigarette smoke in porcine tracheobronchial epithelial cells. Food Chem Toxicol 2006; 44:1590-1596.
52. Morrison JA, Gulley ML, Pathmanathan R, Raab-Traub N: Differential signaling pathways are activated in Epstein-Barr virus associated malignancies nasopharyngeal carcinoma and Hodgkin lymphoma. Cancer Res 2004; 64:5251-5260.
53. Ougolkov AV, Fernandez-Zapico ME, Bilim VN, Smyrk TC, Chari ST, Billadeau DD: Aberrant nuclear accumulation of glycogen synthase kinases-3beta in human pancreatic cancer: association with kinase activity and tumor differentiation. Clin Cancer Res 2006; 12:5074-5081.
54. Shakoori A, Mai W, Miyashita K, Yasumoto K, Takahashi Y, Ooi A, Kawakami K, Minamoto T: Inhibition of GSK3beta activity attenuates proliferation of human colon cancer cells in rodents. Cancer Sci 2007; 98:1388-1393.
55. Cao Q, Lu X, Feng YJ: Glycogen synthase kinase 3beta positively regulates the proliferation of human ovarian cancer cells. Cell Res 2006; 16:671-677.
56. Ding M, He X, Xia W, Hsu JM, Chen CT, Li LY, Lee DF, Yang JY, Xie X, Liu JC, Hung MC: Myeloid cell leukemia-1 inversely correlates with glycogen synthase kinase 3beta activity and associates with poor prognosis in human breast cancer. Cancer Res 2007; 67:4564-4571.
57. Takahashi YF, Sasaguri T: GSK-3beta regulates cyclin D1 expression: a new target for chemotherapy. Cell Signal 2008; 20:581-589.
58. Ding VW, Chen RH, McCormick F: Differential regulation of glycogen synthase kinase 3beta by insulin and Wnt signaling. J Biol Chem 2000; 275:32475-32481.
59. Cselenyi CS, Jarnigan KK, Tahinci E, Thornr CA, Lee LA, Lee E: LRP6 transduces a canonical Wnt signal independently of axin degradation by inhibiting GSK3s phosphorylation of beta-catenin. Proc Natl Acad Sci USA 2008; 105:8032-8037.
60. Piao S, Lee SH, Kim H, Yum H, Stamos JL, Xu Y, Lee SJ, Lee J, Oh S, Han JK, Park BJ, Weis WI, Ha NH: Direct inhibition of GSK3β by the phosphorylated cytoplasmic domain of LRP6 in Wnt/β-catenin signaling. PLoS One 2008; 3:e4046.
61. Wu G, Huang H, Garcia Abreu J, He X: Inhibition of GSK3 phosphorylation of beta-catenin via phosphorylated PPPSPXS motifs of Wnt coreceptor LRP6. PLoS One 2009; 4:e4926.
62. Taelman VF, Dobrowolski R, Plouhinec JL, Fuentelba LC, Vorwald PP, Gumper I, Sabatini DD, De Roberties EM: Wnt signaling requires sequestration of glycogen synthase kinase 3 inside multivesicular endosomes. Cell 2010; 143:1136-1148.
63. Metcalfe C, Bienz M: Inhibition of GSK3 by Wnt signaling-two contrasting models. J Cell Sci 2011; 124:3537-3544.
64. Pan W, Choi SC, Wang H, Qin Y, Volpicelli-Daley L, Swan L, Lucast L, Khoo C, Zhang X, Li L, Abrams CS, Sokol SY, Wu D: Wnt3a-mediated formation of phosphatidylinositol 4, 5-bisphosphate regulates LRP6 phosphorylation. Science 2008; 321:1350-1353.
65. Morrison JA, Klingehutz AJ, Raab-Traub N: Epstein-Barr virus latent membrane protein 2A activates beta-catenin signaling in epithelial cells. J Virol 2003; 77:12276-12284.
66. Fukumoto S, Hsieh CM, Maemura K, Layne MD, Yet SF, Lee KH, Matsui T, Rosenzweig A, Taylor WG, Rubin JS, Perrella MA, Lee ME: Akt participation in the Wnt signaling pathway through Dishevelled. J Biol Chem 2001; 276:17479-17483.
67. Farago M, Dominguez I, Landesman-Bollag E, Xu X, Rosner A, Cadiff RD, Seldin DC: Kinase-inactive glycogen synthase kinase 3beta promotes Wnt signaling and mammary tumorigenesis Cancer Res 2007; 65:5792-5801.
68. Sengupta A, Banerjee D, Chandra S, Banerji SK, Ghosh R, Roy R, Banerjee S: Deregulation and cross talk among Sonic hedgehog, Wnt, Hox and Notch signaling in chronic myeloid leukemia progression Leukemia 2007; 21:949-955.
69. Weng AP, Millholland JM, Yashiro-Ohtani Y, Arcangeli ML, Lau A, Wai C, Bianco CD, Rodriguez CG, Sai H, Tobis J, Li Y, Wolfe MS, Felsher D, Blacklow SC, Pear WS, Aster JC: c-Myc is an important direct target of Notch1 in T-cell acute lymphoblastic leukemia/lymphoma. Genes Dev 2006; 20:2096-2109.
70. Palomero T, Lim WK, Odom DT, Sulis ML, Real PJ, Margolin A, Barnes KC, O'Neil J, Neuberg D, Weng AP, Aster JC, Sigaux F, Soulier J, Look AT, Young RA, Califano A, Ferrando A: NOTCH1 directly regulates c-MYC and activates a feed-forward-loop transcriptional network promoting leukemic cell growth. Proc Natl Acad Sci USA 2006; 103:18261-18266.
71. Tripathi R, Rath G, Jawanjal P, Sharma S, Singhal P, Bhambhani S, Hussain S, Bhardwaj M: Clinical impact of de-regulated Notch-1 and Notch-3 in the development and progression of HPV-associated different histological subtypes of precancerous and cancerous lesions of human uterine cervix. PLoS One 2014; 9:e98642.
72. Yaguchi T, Goto Y, Kido K, Mochimaru H, Sakurai T, Tsukamoto N, Kudo-Saito C, Fujita T, Sumimoto H, Kawakami Y: Immune suppression and resistance mediated by constitutive activation of Wnt/β-catenin signaling in human melanoma cells. J Immunol 2012; 189:2110-2117.